Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1098 | 1041 | 987 | 1253 | 1442 | 2107 |
Fund Return | 9.84% | 4.12% | -1.34% | 7.8% | 7.6% | 7.74% |
Place in category | 273 | 250 | 60 | 345 | 93 | 41 |
% in Category | 45 | 39 | 12 | 65 | 22 | 16 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 9.2B | 34.69 | 8.33 | 12.04 | ||
UBS CH Institutional Fund 2 EquiPAX | 4.61B | 28.90 | 6.79 | 9.56 | ||
UBS CH Vitainvest 50 World U | 4.44B | 8.31 | -0.67 | 2.51 | ||
UBS CH Institutional Fund 2 EquiSCX | 3.17B | 17.20 | 0.81 | 6.76 | ||
UBS CH Institutional Fund 2 EquiSCB | 3.17B | 17.13 | 0.75 | 6.70 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.6B | 7.50 | -0.45 | 5.93 | ||
Raiffeisen Futura Swiss Stock A | 2.23B | 7.81 | -1.29 | 5.90 | ||
UBS CH Equity Fund Swiss Income CHF | 2.25B | 8.29 | 0.69 | 5.71 | ||
CH0502155648 | 2.25B | 9.19 | 1.50 | - | ||
UBS CH Equity Fund Swiss Income CHQ | 2.25B | 9.00 | 1.31 | 6.36 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 19.19 | 74.22 | +0.05% | |
Novartis | CH0012005267 | 12.84 | 90.41 | +0.76% | |
Roche Holding Participation | CH0012032048 | 12.72 | 273.60 | -0.07% | |
UBS Group | CH0244767585 | 7.03 | 31.54 | -0.13% | |
Zurich Insurance Group | CH0011075394 | 6.01 | 538.60 | +0.15% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review